annual FCF:
-$128.68M+$16.98M(+11.66%)Summary
- As of today (June 1, 2025), AXSM annual free cash flow is -$128.68 million, with the most recent change of +$16.98 million (+11.66%) on December 31, 2024.
- During the last 3 years, AXSM annual FCF has fallen by -$20.15 million (-18.56%).
- AXSM annual FCF is now -7789.15% below its all-time high of -$1.63 million, reached on December 31, 2013.
Performance
AXSM Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$43.71M-$17.48M(-66.64%)Summary
- As of today (June 1, 2025), AXSM quarterly free cash flow is -$43.71 million, with the most recent change of -$17.48 million (-66.64%) on March 31, 2025.
- Over the past year, AXSM quarterly FCF has increased by +$9.85 million (+18.39%).
- AXSM quarterly FCF is now -3639.03% below its all-time high of -$1.17 million, reached on March 31, 2015.
Performance
AXSM quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$118.83M+$9.85M(+7.66%)Summary
- As of today (June 1, 2025), AXSM TTM free cash flow is -$118.83 million, with the most recent change of +$9.85 million (+7.66%) on March 31, 2025.
- Over the past year, AXSM TTM FCF has increased by +$74.51 million (+38.54%).
- AXSM TTM FCF is now -10064.06% below its all-time high of -$1.17 million, reached on March 31, 2015.
Performance
AXSM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AXSM Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.7% | +18.4% | +38.5% |
| 3 y3 years | -18.6% | -33.0% | -4.1% |
| 5 y5 years | -177.4% | -87.8% | -97.5% |
AXSM Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.6% | +11.7% | -641.9% | +21.2% | -31.7% | +38.5% |
| 5 y | 5-year | -177.4% | +11.7% | -641.9% | +21.2% | -97.5% | +38.5% |
| alltime | all time | -7789.1% | +11.7% | -3639.0% | +21.2% | <-9999.0% | +38.5% |
AXSM Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$43.71M(+66.6%) | -$118.83M(-7.7%) |
| Dec 2024 | -$128.68M(-11.7%) | -$26.23M(+40.1%) | -$128.68M(-3.1%) |
| Sep 2024 | - | -$18.72M(-37.9%) | -$132.82M(-20.9%) |
| Jun 2024 | - | -$30.16M(-43.7%) | -$168.01M(-13.1%) |
| Mar 2024 | - | -$53.56M(+76.4%) | -$193.34M(+32.7%) |
| Dec 2023 | -$145.66M(+24.3%) | -$30.37M(-43.7%) | -$145.66M(+1.8%) |
| Sep 2023 | - | -$53.92M(-2.8%) | -$143.04M(+27.8%) |
| Jun 2023 | - | -$55.48M(+841.6%) | -$111.94M(+24.1%) |
| Mar 2023 | - | -$5.89M(-78.8%) | -$90.24M(-23.0%) |
| Dec 2022 | -$117.21M(+8.0%) | -$27.74M(+21.6%) | -$117.21M(-0.9%) |
| Sep 2022 | - | -$22.82M(-32.4%) | -$118.31M(-3.4%) |
| Jun 2022 | - | -$33.78M(+2.8%) | -$122.52M(+7.3%) |
| Mar 2022 | - | -$32.87M(+14.0%) | -$114.16M(+5.2%) |
| Dec 2021 | -$108.53M(+38.3%) | -$28.84M(+6.7%) | -$108.53M(+8.2%) |
| Sep 2021 | - | -$27.03M(+6.4%) | -$100.27M(+12.7%) |
| Jun 2021 | - | -$25.41M(-6.7%) | -$88.98M(+7.9%) |
| Mar 2021 | - | -$27.25M(+32.4%) | -$82.47M(+5.0%) |
| Dec 2020 | -$78.50M(+69.2%) | -$20.57M(+30.6%) | -$78.50M(+4.0%) |
| Sep 2020 | - | -$15.75M(-16.7%) | -$75.50M(+7.3%) |
| Jun 2020 | - | -$18.90M(-18.8%) | -$70.38M(+17.0%) |
| Mar 2020 | - | -$23.28M(+32.5%) | -$60.17M(+29.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$46.39M(+54.2%) | -$17.57M(+65.3%) | -$46.39M(+20.1%) |
| Sep 2019 | - | -$10.63M(+22.3%) | -$38.62M(+13.9%) |
| Jun 2019 | - | -$8.69M(-8.5%) | -$33.91M(+3.1%) |
| Mar 2019 | - | -$9.50M(-3.0%) | -$32.89M(+9.3%) |
| Dec 2018 | -$30.09M(+13.6%) | -$9.79M(+65.4%) | -$30.09M(+13.2%) |
| Sep 2018 | - | -$5.92M(-22.9%) | -$26.58M(-2.0%) |
| Jun 2018 | - | -$7.68M(+14.7%) | -$27.11M(+2.2%) |
| Mar 2018 | - | -$6.70M(+6.4%) | -$26.54M(+0.2%) |
| Dec 2017 | -$26.48M(+23.8%) | -$6.29M(-2.5%) | -$26.48M(-3.4%) |
| Sep 2017 | - | -$6.45M(-9.1%) | -$27.41M(+6.1%) |
| Jun 2017 | - | -$7.10M(+6.9%) | -$25.84M(+7.4%) |
| Mar 2017 | - | -$6.64M(-8.1%) | -$24.07M(+12.5%) |
| Dec 2016 | -$21.39M(+186.7%) | -$7.22M(+48.0%) | -$21.39M(+30.3%) |
| Sep 2016 | - | -$4.88M(-8.4%) | -$16.42M(+21.9%) |
| Jun 2016 | - | -$5.33M(+34.6%) | -$13.47M(+31.4%) |
| Mar 2016 | - | -$3.96M(+75.5%) | -$10.25M(+37.4%) |
| Dec 2015 | -$7.46M(+62.3%) | -$2.25M(+17.0%) | -$7.46M(+43.3%) |
| Sep 2015 | - | -$1.93M(-8.6%) | -$5.20M(+58.8%) |
| Jun 2015 | - | -$2.11M(+80.3%) | -$3.28M(+180.3%) |
| Mar 2015 | - | -$1.17M | -$1.17M |
| Dec 2014 | -$4.60M(+181.8%) | - | - |
| Dec 2013 | -$1.63M | - | - |
FAQ
- What is Axsome Therapeutics annual free cash flow?
- What is the all time high annual FCF for Axsome Therapeutics?
- What is Axsome Therapeutics annual FCF year-on-year change?
- What is Axsome Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly FCF year-on-year change?
- What is Axsome Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Axsome Therapeutics?
- What is Axsome Therapeutics TTM FCF year-on-year change?
What is Axsome Therapeutics annual free cash flow?
The current annual FCF of AXSM is -$128.68M
What is the all time high annual FCF for Axsome Therapeutics?
Axsome Therapeutics all-time high annual free cash flow is -$1.63M
What is Axsome Therapeutics annual FCF year-on-year change?
Over the past year, AXSM annual free cash flow has changed by +$16.98M (+11.66%)
What is Axsome Therapeutics quarterly free cash flow?
The current quarterly FCF of AXSM is -$43.71M
What is the all time high quarterly FCF for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly free cash flow is -$1.17M
What is Axsome Therapeutics quarterly FCF year-on-year change?
Over the past year, AXSM quarterly free cash flow has changed by +$9.85M (+18.39%)
What is Axsome Therapeutics TTM free cash flow?
The current TTM FCF of AXSM is -$118.83M
What is the all time high TTM FCF for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM free cash flow is -$1.17M
What is Axsome Therapeutics TTM FCF year-on-year change?
Over the past year, AXSM TTM free cash flow has changed by +$74.51M (+38.54%)